Distinguished in Atherosclerosis

Dr. Gary M. Ansel

Interventional Cardiology | Cardiology
3705 Olentangy River Rd, Suite 100, 
Columbus, OH 
Accepting New Patients
Distinguished in Atherosclerosis
3705 Olentangy River Rd, Suite 100, 
Columbus, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Gary Ansel is an Interventional Cardiologist and a Cardiologist in Columbus, Ohio. Dr. Ansel is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Carotid Artery Disease, Atherosclerosis, Angioplasty, and Stent Placement. Dr. Ansel is currently accepting new patients.

His clinical research consists of co-authoring 66 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 36 articles and participated in 9 clinical trials in the study of Atherosclerosis.

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Medical Mutual
  • HMO
  • PPO

Locations

3705 Olentangy River Rd, Suite 100, Columbus, OH 43214

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Device, Other, Procedure
Study Phase: Not Applicable
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics
Enrollment Status: Active_not_recruiting
Publish Date: September 26, 2025
Intervention Type: Procedure, Other
Study Phase: Phase 3
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI)
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI)
Enrollment Status: Terminated
Publish Date: April 11, 2025
Intervention Type: Diagnostic test
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Enrollment Status: Completed
Publish Date: March 25, 2025
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System: A Pivotal and Continued Access Study
Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System: A Pivotal and Continued Access Study
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Device
Study Phase: Not Applicable
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Randomized Study of the Shockwave Medical Peripheral Lithoplasty® System Used in Combination With DCB Versus Standard Balloon Angioplasty Used in Combination With DCB to Treat Moderate and Severely Calcified Femoropopliteal Arteries
Enrollment Status: Completed
Publish Date: December 20, 2023
Intervention Type: Device, Drug
Study Phase: Not Applicable
Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia
Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: April 11, 2023
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery
A Prospective, Multi-Center, Single-Arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects With De Novo Lesions of the Femoropopliteal Artery
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients With Resistant Hypertension
ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients With Resistant Hypertension
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Device
Study Phase: Not Applicable
Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)
Enrollment Status: Completed
Publish Date: November 14, 2018
Intervention Type: Combination product
Study Phase: Phase 1
View 11 Less Clinical Trials

66 Total Publications

Endovascular treatment of peripheral arterial disease: Endo-STAR framework for the design, conduct, and reporting of trials.
Endovascular treatment of peripheral arterial disease: Endo-STAR framework for the design, conduct, and reporting of trials.
Journal: The British journal of surgery
Published: December 07, 2024
Similar Doctors
Distinguished in Atherosclerosis
Dr. Nathan H. Kander
Interventional Cardiology | Cardiology
Distinguished in Atherosclerosis
Dr. Nathan H. Kander
Interventional Cardiology | Cardiology

Ohiohealth Corporation

3705 Olentangy River Rd, Suite 100, 
Columbus, OH 
 (0.1 miles away)
614-262-6722
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Nathan Kander is an Interventional Cardiologist and a Cardiologist in Columbus, Ohio. Dr. Kander is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Heart Attack, Atherosclerosis, Angioplasty, and Aortic Valve Replacement. Dr. Kander is currently accepting new patients.

Distinguished in Atherosclerosis
Dr. Abdulhay Albirini
Interventional Cardiology | Cardiology
Distinguished in Atherosclerosis
Dr. Abdulhay Albirini
Interventional Cardiology | Cardiology

Genesis Medical Group, LLC

955 Bethesda Dr, Fl 1, 
Zanesville, OH 
 (54.0 miles away)
740-454-0804
Languages Spoken:
English, Arabic, Arabic - Jordanian
See accepted insurances
Accepting New Patients

Abdulhay Albirini is an Interventional Cardiologist and a Cardiologist in Zanesville, Ohio. Dr. Albirini is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Pacemaker Implantation, and Heart Bypass Surgery. Dr. Albirini is currently accepting new patients.

Distinguished in Atherosclerosis
Dr. James P. Bacon
Cardiology | Interventional Cardiology
Distinguished in Atherosclerosis
Dr. James P. Bacon
Cardiology | Interventional Cardiology
335 Glessner Ave, 
Mansfield, OH 
 (56.2 miles away)
419-524-8151
Languages Spoken:
English
See accepted insurances
Accepting New Patients

James Bacon is a Cardiologist and an Interventional Cardiologist in Mansfield, Ohio. Dr. Bacon is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, Heart Bypass Surgery, and Bone Marrow Aspiration. Dr. Bacon is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ansel's expertise for a condition
ConditionClose
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile